⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for androgen deprivation

Every month we try and update this database with for androgen deprivation cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Salvage Therapeutic Radiation With Enzalutamide and ADT in Men With Recurrent Prostate Cancer (STREAM)NCT02057939
Prostate Cancer
enzalutamide
Androgen Depriv...
Radiation Thera...
18 Years - Duke University
A Study of Abiraterone Acetate (JNJ-212082) and Prednisolone in Patients With Advanced Prostate CancerNCT01685983
Prostate Cancer
Abiraterone ace...
Prednisolone
18 Years - Janssen Research & Development, LLC
A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate CancerNCT05100472
Prostate Cancer
Androgen depriv...
Brachytherapy
Hypofractionate...
18 Years - Memorial Sloan Kettering Cancer Center
Effect of Soy on Cognition and Hot Flashes in Men With Prostate Cancer Undergoing Testosterone Suppression TherapyNCT00245518
Hot Flashes
Isoflavone
Placebos
21 Years - Johns Hopkins University
RADAR Trial - Randomised Androgen Deprivation and RadiotherapyNCT00193856
Prostate Cancer
Leuprorelin Ace...
Zoledronic Acid
Conventional ex...
18 Years - Trans Tasman Radiation Oncology Group
A Study of Definitive Therapy to Treat Prostate Cancer After ProstatectomyNCT03043807
Prostate Cancer
Leuprolide Acet...
Docetaxel
Bicalutamide
Radiation
Abiraterone Ace...
18 Years - 80 YearsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
A Study of Abiraterone Acetate (JNJ-212082) and Prednisolone in Patients With Advanced Prostate CancerNCT01685983
Prostate Cancer
Abiraterone ace...
Prednisolone
18 Years - Janssen Research & Development, LLC
Docetaxel, Bevacizumab and Androgen Deprivation Therapy After Definitive Local Therapy for Prostate CancerNCT00658697
Prostate Cancer
Docetaxel
Bevacizumab
ADT
Bicalutamide
18 Years - Dana-Farber Cancer Institute
Safety Study of Pelvic and Prostatic SIB-IMRT With Long-term Androgen Deprivation for High Risk Localized Prostate CancerNCT01704027
Prostate Cancer
Simultaneous in...
Androgen depriv...
18 Years - 85 YearsCentre Georges Francois Leclerc
Prevention of Micro-architectural Bone Decay in Males With Non-metastatic Prostate Cancer Receiving Androgen Deprivation Therapy (ADT)NCT01006395
Prostate Cancer
Zoledronic acid
Placebo
18 Years - 75 YearsAustin Health
Salvage Therapeutic Radiation With Enzalutamide and ADT in Men With Recurrent Prostate Cancer (STREAM)NCT02057939
Prostate Cancer
enzalutamide
Androgen Depriv...
Radiation Thera...
18 Years - Duke University
Androgen Deprivation Therapy in Advanced Salivary Gland CancerNCT01969578
Salivary Gland ...
bicalutamide + ...
Cisplatin + Dox...
Carboplatin + P...
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Stereotactic Boost and Long-Term Androgen Deprivation for Adenocarcinoma of the ProstateNCT02064036
Adenocarcinoma ...
Stereotactic Ra...
Casodex
Leuprolide
18 Years - University of California, Davis
Impact of Radical Prostatectomy as Primary Treatment in Patients With Prostate Cancer With Limited Bone MetastasesNCT02454543
Prostate Cancer
Radical prostat...
Best systemic t...
18 Years - 75 YearsMartini-Klinik am UKE GmbH
Abiraterone, Radiotherapy and Short-Term Androgen Deprivation in Unfavorable Localized Prostate CancerNCT01717053
Prostate Cancer
Abiraterone ace...
Androgen depriv...
Radiation Thera...
Prednisone
18 Years - Duke University
Safety Study of Pelvic and Prostatic SIB-IMRT With Long-term Androgen Deprivation for High Risk Localized Prostate CancerNCT01704027
Prostate Cancer
Simultaneous in...
Androgen depriv...
18 Years - 85 YearsCentre Georges Francois Leclerc
Impact of Radical Prostatectomy as Primary Treatment in Patients With Prostate Cancer With Limited Bone MetastasesNCT02454543
Prostate Cancer
Radical prostat...
Best systemic t...
18 Years - 75 YearsMartini-Klinik am UKE GmbH
Prevention of Micro-architectural Bone Decay in Males With Non-metastatic Prostate Cancer Receiving Androgen Deprivation Therapy (ADT)NCT01006395
Prostate Cancer
Zoledronic acid
Placebo
18 Years - 75 YearsAustin Health
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: